Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$404,397,184
-$52,077,305 QoQ
Shares Held
16,793,903
+3.3% QoQ
Ownership
0.295%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
#36
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pacer Advisors, Inc. holds $1,720,661,138 across 10 Drug Manufacturers - General names. PFE ranks #2 (23.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
7,995,711 | $460,712,867 | |
| 2 | PFE |
Pfizer Inc
This page
|
16,793,903 | $404,397,184 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
3,110,000 | $392,917,400 | |
| 4 | BIIB |
Biogen Inc.
|
1,122,981 | $242,631,274 | |
| 5 | LLY |
ELI LILLY & Co
|
59,898 | $71,843,464 | |
| 6 | ABBV |
AbbVie Inc.
|
201,334 | $50,663,687 | |
| 7 | JNJ |
Johnson & Johnson
|
183,172 | $46,520,192 | |
| 8 | AMGN |
Amgen Inc
|
74,159 | $26,854,457 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $404,397,184 | 16,793,903 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $456,474,489 | 16,256,214 | Shares | Sole | 2026-06-18 | |
| 2025-12-31 | $403,213,867 | 16,193,328 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $447,807,203 | 17,574,851 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $481,389,432 | 19,859,300 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $508,164,001 | 20,053,828 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $55,604,227 | 2,095,900 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $12,479,854 | 431,232 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $11,484,754 | 410,463 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $45,695,148 | 1,646,672 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $46,284,214 | 1,607,649 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $341,110,494 | 10,283,705 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $288,742,465 | 7,871,932 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $283,019,277 | 6,936,747 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $222,354,596 | 4,339,473 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $143,599,096 | 3,281,515 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $134,567,309 | 2,566,609 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $93,529,390 | 1,806,633 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $43,681,292 | 739,734 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $34,862,443 | 810,566 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $16,556,299 | 422,786 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $13,248,731 | 365,684 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $14,349,126 | 389,816 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $17,657,637 | 481,135 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $18,214,507 | 557,018 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $2,934,593 | 89,908 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||